Be the first to know about new products & special offers from Pure Health Peptides
Eur J Endocrinol 1998;139:552-561
This article describes AUA guidelines for the diagnosis and treatment of IC/BPS, clearly defining IC/BPS as different subgroups or phenotypes and recommending multimodal therapies that depend on the clinical characteristics and urological findings
Proper contaminant screening should cover at minimum heavy metals, microbial counts, endotoxins, and residual solvents
Systematic reviews of BPC-157 in musculoskeletal applications identified 36 studies demonstrating improved functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bone injuries in preclinical models
These findings were noted both in the presence and absence of continuous positive airway pressure (CPAP) therapy [86,87,88,89]